Reference
Staab TR, et al. "Market withdrawals" of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations. Health Economics Review 2018: 23, No. 8, 18 Sep 2018. Available from: URL: https://doi.org/10.1186/s13561-018-0209-3
Rights and permissions
About this article
Cite this article
Market withdrawals in Germany: recommendations differ. PharmacoEcon Outcomes News 813, 18 (2018). https://doi.org/10.1007/s40274-018-5325-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5325-0